期刊文献+

急性冠状动脉综合征患者心肌酶和肌钙蛋白I变化的临床分析 被引量:1

下载PDF
导出
摘要 目的探讨急性冠状动脉综合征(ACS)患者心电图、肌酸磷酸激酶同功酶(CK-MB)肌钙蛋白I(CTnI)三者间变化的临床意义。方法选择2003年1月~2006年3月在我院心内科住院且记录资料完整的患者89例。患者入院后仔细询问病史、查体、立即完成常规12导联心电图检查,入院时及入院后8小时各采静脉血测定血清CK-MB和CTnI。结果ACS患者ST段抬高组中CK-MB和CTnI的检测阳性率明显高于非ST段抬高组,差异有统计学意义(P<0.01)。ST段抬高组中CTnI检测阳性率高于CK-MB检测阳性率,但差异无统计学意义(P>0.01)。非ST段抬高组中CTnI检测阳性率高于CK-MB检测阳性率,差异有统计学意义(P<0.01)。结论ACS患者中ST段抬高者心肌损伤的发生率明显大于非ST段抬高者,CTnI对于心肌轻微损伤的检测阳性率高于CK-MB。
作者 孙桂兰
出处 《安徽医学》 2008年第2期175-176,共2页 Anhui Medical Journal
  • 相关文献

参考文献4

二级参考文献16

  • 1赵明中,胡大一,陈学英,朱天刚,许玉韵.心肌梗死溶栓疗法危险评分在老年无ST段抬高急性冠状动脉综合征患者预后评估中的应用价值[J].中华医学杂志,2004,84(13):1103-1104. 被引量:6
  • 2Wallentin L,Lagerqvist B, Husted S. For the FRISC ⅡInvestigators: outcome at 1 year after an invasive compared to a non-invasive strategy in unstable coronary artery disease: the FRISC Ⅱ invasive randomised trial. Lancet,2000,356:9-16.
  • 3Cannon CP,Weintraub WS,Demopoulos LA,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban. N Engl J Med,2001,344:1879-1887.
  • 4Fox KAA, Poole-Wilson PA, Henderson RA,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA-3 randomized trial. Lancet,2002,360:743-751.
  • 5Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment(cooling-off strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA,2003,290:1593-1599.
  • 6Braunwald E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. Circulation,2003,108(Suppl): Ⅲ28-Ⅲ37.
  • 7Cannon CP, McCabe CH, Stone PH,et al.For the TIMI Ⅲ Registry ECG Ancillary Study Investigators. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI Ⅲ Registry ECG Ancillary Study. J Am Coll Cardiol,1997,30:133-140.
  • 8Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of framinlgham risk scores. Circulation,2004,109:1955-1959.
  • 9Sabatine MS, McCabe CH, Morrow DA,et al. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J, 2002,143:966-970.
  • 10Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation, 1985,71:699-708.

共引文献68

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部